Early Access — free while we kick the tires
EdgarHawk

Matthew W Calkins

CEO and President

Director Officer 10% Owner

Latest: CEO and President selling · July 2026

2 filings analyzed · 1 company · Latest 2026-07-08

Never miss a filing from Matthew W Calkins

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
APPIAN CORP APPN 0 2 Net selling

Activity

July 2026
2026-07-08 APPIAN CORP APPN 10b5-1 Plan
low
Sell
50,000 shares
$1,236,243
Significance 3/10

CEO Matthew W Calkins sold 50,000 shares at $24.72 avg ($1.2M) via pre-arranged 10b5-1 plan; holds 1.72M post-sale.

Matthew W Calkins, CEO and President, executed 2 separate sales totaling 50,000 shares for $1,236,243.10 on 2026-07-07 under a 10b5-1 trading plan adopted on 2026-03-05. The scheduled nature of this transaction precludes any interpretation of timing judgment or market sentiment. His post-transaction holdings of 1,719,144 shares represent a -2.8% reduction from pre-transaction holdings of 1,769,144 shares. The stock currently trades at $24.27, down 47.3% from the 52-week high of $46.06, and the company reported a net loss of $1,525,000 in the latest quarter despite 17.8% annual revenue growth. The prior sale at APPN on 2026-06-08 returned 0.6% over 30 days, establishing a measured pattern of activity at this ticker.

June 2026
2026-06-10 APPIAN CORP APPN 10b5-1 Plan
low
Sell
50,000 shares
$1,206,500
Significance 3/10

CEO Matthew W Calkins sold 50,000 shares of APPN at $24.13 on 2026-06-08 via pre-arranged 10b5-1 plan; stock -47.9% from 52-week high.

Matthew W Calkins, CEO and President, sold 50,000 shares at $24.13 for $1,206,500.00 on 2026-06-08 under a 10b5-1 trading plan adopted on 2026-03-05, meaning this sale was scheduled and not discretionary. Post-transaction, Calkins retains 1,769,144 shares. The stock currently trades at $24.01, down -47.9% from the 52-week high of $46.06, though it has risen +28.3% over the prior 30 days. Appian reported latest-quarter revenue of $202,180,000.00 and net income of -$1,525,000.00, with annual revenue growth of +17.8%, indicating growth in top line despite current-period losses. The pre-arranged nature of this sale precludes any inference about Calkins's current conviction or market timing; investors should monitor whether scheduled 10b5-1 sales continue as planned and track whether the company's profitability trajectory improves given the recent revenue strength.

Related insiders